Women Engaging in Quitting Smoking Together (WE QUIT)

Butler Hospital

Status: Completed

Conditions: Smoking Cessation

Treatments: Behavioral: Distress Tolerance Treatment for Weight Concern (DT-W); Behavioral: Health Education (HE)

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT02051803

1303-003

K23DA035288 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The long-term goal of this program of research is to develop and disseminate an efficacious intervention for weight concern that will significantly increase smoking cessation rates among women. The overall objective of this project is to develop this intervention and modify it based on piloting and feedback to ensure its feasibility and acceptability. These objectives will be accomplished by pursuing the following specific aim: 1) develop a group-based distress tolerance treatment for weight concern (DT-W) in female smokers and a comparison health education (HE) program and pilot both treatments with three groups of 10 (total N = 30) female weight-concerned smokers (2 DT-W groups, 1 HE group).

Enrollment: 22 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• female
• 18 to 65 years of age
• smoke 10 or more cigarettes per day
• daily smoker for at least the past year
• report motivation to quit smoking in the next month of at least 5 on a 10 point scale
• report concern of at least 50 on at least one of two 100 point scales assessing weight concern
• able to travel to study location for study appointments

Exclusion criteria

• current use of other smoking cessation or weight loss therapies
• current use of other tobacco products at least weekly
• current diagnosis of depression
• diagnosis or treatment for non-nicotine substance use disorder with substance use during the past 6 months
• lifetime diagnosis or treatment of eating disorder, bipolar disorder, schizophrenia, or schizoaffective disorder
• current use of psychotropic medication except antidepressants
• score above established cut-offs on self-report screening measures of depressive symptomology, eating disorder symptomology, alcohol use disorder, or drug use disorder
• current suicidality or homicidality
• medical condition that is a contraindication for the use of transdermal nicotine patch
• lives at same address as current or past participant

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

22 participants in 2 patient groups

Distress Tolerance Treatment for Weight Concern (DT-W)

Experimental group

Description:

DT-W is delivered over a 9 week period with 1 1-hr individual session during week 1, 8 weekly 1.5-hr group counseling sessions during weeks 2-9, and 1 20-minute individual telephone session during week 4. Session content includes distress tolerance intervention for weight concern plus standard behavioral smoking cessation treatment. Participants also receive 8 weeks of nicotine patch.

Treatment:

Behavioral: Distress Tolerance Treatment for Weight Concern (DT-W)

Health Education (HE)

Active Comparator group

Description:

HE is delivered over a 9 week period with 1 1-hr individual session during week 1, 8 weekly 1.5-hr group counseling sessions during weeks 2-9, and 1 20-minute individual telephone session during week 4. Session content includes smoking health education program plus standard behavioral smoking cessation treatment. Participants also receive 8 weeks of nicotine patch.

Treatment:

Behavioral: Health Education (HE)